Incidence of Malignant Melanoma — the most aggressively deadly type of skin cancer — is increasing globally. According to the Skin Cancer Foundation, one person dies of melanoma in the U.S. every 57 minutes, with an estimated 73,870 new cases of invasive melanoma to be diagnosed, including six percent of cancer cases in teens 15-19 years old, with a projected 9,940 people to die of melanoma in the US in 2015, and melanoma is the only skin cancer category whose incidence is increasing, climbing 1.9 percent annually between 2000 and 2009.
The International Agency for Research on Cancer, an affiliate of the World Health Organization, includes ultraviolet (UV) tanning devices in its Group 1 list of the most dangerous cancer-causing substances, which also includes agents such as plutonium, cigarettes, and solar UV radiation. More people develop skin cancer because of tanning than develop lung cancer because of smoking.
From 1973 to 2004 in young people age 15 to 39, melanoma incidence among males increased by 61 percent and incidence among females more than doubled. Women aged 39 and under have a higher probability of developing melanoma than any other cancer except breast cancer, although the majority of people diagnosed with melanoma are white men over age 50.
Globally, Cancer Research UK reports that approximately 13,300 cases of malignant melanoma were diagnosed in 2011 in the UK, a rate of 37 people (including two young adults aged 15-34) every day, making it the second most common cancer in that age group, and over the past thirty years, rates of malignant melanoma in Great Britain have risen faster than any of the other current ten most common cancers, increasing more than fivefold since the mid-1970s.
In Europe, more than 100,000 new cases of malignant melanoma were estimated to have been diagnosed in 2012, while worldwide, around 232,000 people were estimated to have been diagnosed with malignant melanoma during that year, with incidence rates varying across the world. Approximately 2,100 people died from malignant melanoma in 2012 in the UK — roughly 6 every day, while in Europe, around 22,200 people and worldwide some 55,500 were estimated to have died from malignant melanoma in 2012, with mortality rates varying across the world.
In the U.S. Melanoma is the most common form of cancer for young adults 25-29 years old and the second most common form of cancer for young people 15-29 years old, with about 86 percent of melanomas attributable to exposure to ultraviolet (UV) radiation from the sun — a proven human carcinogen. On average, a person’s risk for melanoma doubles if he or she has had more than five sunburns — lifetime — and sustaining five or more sunburns in youth increases lifetime melanoma risk by 80 percent. Roughly half of all adults aged 18-29 report at least one sunburn in the past 12 months. However, regular daily use of an SPF 15 or higher sunscreen reduces risk of developing melanoma by 50 percent.
Heredity also plays a major role in melanoma, with about one in every 10 patients diagnosed with the disease having a family member with a history of melanoma. If your mother, father, siblings or children have had a melanoma, you are in a melanoma-prone family. Each person with a first-degree relative diagnosed with melanoma has a 50 percent greater chance of developing the disease than people who do not have a family history of the disease.
During recent years, there has been considerable growth in the number of mobile applications for melanoma detection, with various types of mobile applications available on platforms such as Apple’s iOS, Google’s Android, Windows Mobile OS and the Blackberry OS. These mobile applications can be subcategorized into algorithm analysis applications, educational applications, mole tracking and reminder applications and interactive teaching applications.
Algorithm analysis applications provide features for analysis of the moles using image processing. The educational and interactive teaching applications provide information regarding ABCDEs of melanoma detection (“asymmetry, border, color, diameter, and evolving”) and help in self-screening of melanoma. Mole tracking and reminder applications offer tracking of suspicious looking or behaving dermal moles that can potentially lead to melanoma, and remind patients of scheduled clinical visits.
A new research report from Transparency Market Research, a market intelligence company providing global business information reports and services, provides an in-depth analysis of mobile applications for melanoma detection for the overall Europe market, with country level analyses for Greece and Israel also included in the study. Additionally, the report analyzes the factors that drive and restrain the growth of the mobile applications for melanoma detection market in Europe, and also discusses prevailing market trends, prospective growth opportunities, and major strategies for increasing the popularity of mobile applications for melanoma detection. It also provides the market estimates and forecasts for Europe, Greece and Israel in terms of revenue, and ranks the market positioning of key players providing mobile applications for melanoma detection in Europe market.
The report also includes competitive profiling of major mobile application developer companies developing applications for melanoma detection. These profiles includes information such as developer/company information, country of origin, type of application, total number of downloads by platform, application features and price of the application. The key mobile applications for melanoma detection profiled in this study include Dr. Mole, LovemySkin, Mole Monitor, MoleTrac, SkinVision, FotoSKin, Dermatology Planet, Mole Check, Mollie’s Fund, N?vus, OnlineDermClinic, Skin Analytics, Skin Cancer, Skin Doctor, Spot Mole, Spot Mole Plus, SpotCheck, iSkin, Melanoma Watch, Mole Checker, Mole Checker/Stroika, MoleQuest, Mole Doctor, Skin Of Mine, Skin Prevention, Skin Scanner, Skin Tagger, Skin Mole Analysis, Track-A-Mole, YourSkinDiary and UMSkinCheck.
The 69 page report, “Mobile Applications for Melanoma Detection Market – Europe and Israel Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022 by Transparency Market Research Table of Contents can be found here:
The full report can be purchased at:
Transparency Market Research
The Skin Cancer Foundation
Cancer Research UK
The International Agency for Research on Cancer (WHO)